StockData
Immuron Ltd logo

Immuron Ltd (IMRN) stock

IMRNNasdaqPharmaceutical PreparationsFiscal year ends June 30
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Sep 24, 2026Score 4/30
$0.88−0.03 (-3.52%)

Close on Nov 13, 2026Market cap $7.06MP/E –Yield –

Immuron statistics

68 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Jun 30, 2026
Share price as of
–

Valuation ratiosIndustry

Market Cap
A$10.28M
A$15.59M
Enterprise Value
A$1.26M
A$1.26M
PS Ratio
1.33
–

Enterprise valuationIndustry

EV / Sales
0.16
–

Share statisticsIndustry

Shares Change (YoY)
28.6%
28.6%
Float
317M
317M
Shares Held by Insiders
1.94%
1.94%
Shares Held by Institutions
0.02%
–

Short sellingIndustry

Short Interest
26,156
–
Short Interest Change
-60.6%
-27.5%
Days to Cover
1.65
2.08

Stock price statisticsIndustry

Price Change (1 Week)
5.31%
-7.80%
Price Change (1 Month)
-15.0%
-11.7%
Price Change (3 Months)
-19.0%
-51.2%
Price Change (6 Months)
-12.9%
-49.7%
Price Change (YTD)
14.8%
-36.4%
Price Change (1 Year)
-45.6%
-48.3%
Price Change (3 Years)
-53.7%
–
Price Change (5 Years)
-75.9%
–
Price Change (10 Years)
-99.8%
–
Average Volume (10 Days)
19,599
–
Average Volume (20 Days)
17,519
–
Average Volume (90 Days)
1M
–
Relative Volume
0.01
0.81
Relative Strength Index (14)
39.7
31.9
Volatility (1 Year)
107.1%
128.1%
Beta (5 Years)
0.37
1.38

MarginsIndustry

Gross Margin
64.5%
–
Pretax Margin
-47.7%
–
Profit Margin
-47.7%
–
EBITDA Margin
-49.4%
–
FCF Margin
-42.3%
–

Returns on capitalIndustry

Return on Assets (ROA)
-31.6%
–
Return on Capital Employed (ROCE)
-33.9%
–

Financial positionIndustry

Current Ratio
7.26
5.69
Quick Ratio
5.84
5.16
Interest Coverage
-261.74
–

GrowthIndustry

Revenue Growth (YoY)
5.85%
–
Revenue Growth (3Y CAGR)
62.3%
–
Revenue Growth (5Y CAGR)
121.2%
–

EfficiencyIndustry

Asset Turnover
0.66
–
Inventory Turnover
1.35
–
Revenue Per Employee
A$1.10M
–
Profits Per Employee
-A$525.71K
–
Employee Count
7
–
WACC
7.60%
12.0%

Income statement (TTM)Industry

Revenue
A$7.71M
–
Gross Profit
A$4.98M
–
Operating Income
-A$3.85M
–
Pretax Income
-A$3.68M
-A$22.45M
Net Income
-A$3.68M
–
EBITDA
-A$3.81M
–
EPS (Diluted)
-1.24 AUD
–

Balance sheetIndustry

Net Cash (Debt)
A$9.02M
A$37.32M
Net Cash Per Share
0.03 AUD
0.04 AUD
Working Capital
A$11.17M
A$42.67M

Cash flow (TTM)Industry

Operating Cash Flow
-A$3.26M
-A$13.28M
Capital Expenditures
-A$4.75K
–
Free Cash Flow
-A$3.26M
–
FCF Per Share
-0.01 AUD
–

Dividends and yieldsIndustry

Earnings Yield
-35.8%
–
FCF Yield
-31.8%
–

Taxes and interestIndustry

Interest Expense
A$14.71K
–

Scores and fair valueIndustry

Altman Z-Score
-5.30
-1.72
Piotroski F-Score
5
–

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

PeriodIMRNS&P 500DifferenceIMRN per yearS&P 500 per year
1 month-15.8%-3.0%−12.8 pts
3 months-22.5%-2.8%−19.8 pts
Year to date+14.8%+11.5%+3.3 pts
1 year-43.9%+13.5%−57.4 pts
3 years-48.5%+77.7%−126.2 pts-19.9%+21.1%
5 years-75.9%+72.6%−148.5 pts-24.8%+11.5%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M IMRN shares were sold short on Oct 30, 2026, down 60.6% from the previous report. At recent volumes it would take 1.6 days to buy them back. Over the last 20 sessions, 37.3% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202626,156-60.6%15,9001.6
Oct 15, 202666,371+7.5%47,9611.4
Sep 30, 202661,753-46.6%109,6951.0
Sep 15, 2026115,685+240.2%12,663,7891.0
Aug 31, 202634,009-14.8%15,1012.3
Aug 14, 202639,935+10.3%17,3162.3
Jul 31, 202636,212-54.1%30,0801.2
Jul 15, 202678,837+6.9%68,2311.2
Jun 30, 202673,743-48.4%37,6932.0
Jun 15, 2026142,940-73.2%79,7691.8
May 29, 2026532,563+1917.5%1,375,8041.0
May 15, 202626,397+35.9%47,5871.0

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?